Document 0714 DOCN M9590714 TI NIH Conference Retroviral Integrase. DT 9509 AU Skalka AM SO NIH Conf Retroviral Integrase. 1995 Jan 19-20;:(Session II, speakers' abstracts - unpaged). Unique Identifier : AIDSLINE AIDS/95920005 AB The general outline of the integration pathway has been known for some time. DNA is synthesized within a subviral particle that is deposited in the cytoplasm of the infected cell after entry and uncoating of the virion. The first biochemical step, an endonucleolytic processing by which IN removes two nucleotides from the 3' ends of this DNA, can take place immediately after DNA synthesis is completed. The resulting preintegration complex must then make its way to the nucleus of the infected cell where the second biochemical step takes place: a concerted cleavage and ligation that results in the joining of viral and cell DNA. The development of reconstituted in vitro systems that employ purified IN and model DNA substrates have made it possible to explore several aspects of the biochemistry of this reaction. However, many questions remain concerning the organization and structure of components in vivo, such as how viral and cell components interact, and how the structure of IN relates to the various functions of the enzyme. This report will present an update on our most recent findings concerning the structure of IN and its relationship to activities measured both in vitro and in vivo. They include the identification of a nuclear localization signal and self-association determinants in RSV IN, and the construction and analysis of novel substrates that may provide clues to the organization of viral DNA ends in the coordinated processing reaction that occurs in vivo. DE Cytoplasm/VIROLOGY DNA Nucleotidyltransferases/*METABOLISM DNA, Viral/*GENETICS/METABOLISM Protein Processing, Post-Translational Retroviridae/*ENZYMOLOGY Virion Virus Integration/*GENETICS MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).